International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients

Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study

(2019) Hidde M. Kroon et al.   EJSO

Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis

(2019) John T. Miura et al.   ANNALS OF SURGICAL ONCOLOGY

Age-Specific Incidence of Melanoma in the United States

(2019) Kelly G. Paulson et al.   JAMA Dermatology

Regional therapies for locoregionally advanced and unresectable melanoma

(2018) Evan S. Weitman et al.   CLINICAL & EXPERIMENTAL METASTASIS

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

(2018) Alexander M.M. Eggermont et al.   NEW ENGLAND JOURNAL OF MEDICINE

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

(2018) Charlotte E. Ariyan et al.   Cancer Immunology Research

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

(2017) Jeffrey Weber et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks

(2017) Jan R. Aunan et al.   Aging and Disease

Intralesional and systemic immunotherapy for metastatic melanoma

(2016) Carrie Luu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031

(2016) David C. Whiteman et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

(2016) Alexander M.M. Eggermont et al.   NEW ENGLAND JOURNAL OF MEDICINE

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

(2015) Robert H.I. Andtbacka et al.   JOURNAL OF CLINICAL ONCOLOGY

Causes, consequences, and reversal of immune system aging

(2013) Encarnacion Montecino-Rodriguez et al.   JOURNAL OF CLINICAL INVESTIGATION

Isolated limb infusion: Technical aspects

(2013) Hidde M. Kroon et al.   JOURNAL OF SURGICAL ONCOLOGY

A Phase I Multi-Institutional Study of Systemic Sorafenib in Conjunction with Regional Melphalan for In-Transit Melanoma of the Extremity

(2012) G. M. Beasley et al.   ANNALS OF SURGICAL ONCOLOGY

Isolated Limb Perfusion and Isolated Limb Infusion for Malignant Lesions of the Extremities

(2011) Amira Sanki et al.   CURRENT PROBLEMS IN SURGERY

Intra-lesional interleukin-2 for the treatment of in-transit melanoma

(2011) Kirsty U. Boyd et al.   JOURNAL OF SURGICAL ONCOLOGY

Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety

(2010) D. Moreno-Ramirez et al.   ONCOLOGIST

Safety and Efficacy of Isolated Limb Infusion With Cytotoxic Drugs in Elderly Patients With Advanced Locoregional Melanoma

(2009) Hidde M. Kroon et al.   ANNALS OF SURGERY

Isolated Limb Infusion as Palliative Treatment for Advanced Limb Disease in Patients with AJCC Stage IV Melanoma

(2009) Hidde M. Kroon et al.   ANNALS OF SURGICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US

(2009) Georgia M. Beasley et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion

(2008) Georgia M. Beasley et al.   ANNALS OF SURGICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER